Singer Celine Dion opens up about her health battle with Stiff-Person Syndrome

Celine Dion is pressing forward after a health battle that threatened to permanently silence one of music's most celebrated voices, opening up about living with Stiff-Person Syndrome in a cover interview for Harper's Bazaar's September ICONS issue, That Grape Juice reported. Dion's diagnosis arrived in 2022, though she says she had experienced symptoms for roughly 17 years before doctors identified the condition.

At their worst, the spasms and stiffness associated with the rare neurological condition left Dion struggling to walk, sing or function normally. Since her diagnosis, she has undergone an intensive rehabilitation process that includes new medication, physical and vocal therapy, and immunotherapy, work that continues as she prepares for the physical demands of performing again. Dion now does 90-minute Pilates sessions three times a week, along with ballet classes on two additional days.

Fans got an unfiltered look at how severe her health crisis became in the 2024 documentary I Am: Celine Dion, which captured moments of pain the star had previously kept private. Dion said opening up to that degree was ultimately about honoring the people who supported her career. "They paid for tickets. They bought my records. They gave me that luxury," she said. "So the least I can do is tell them that I'm alive."

The years away also changed how Dion saw herself outside the constant cycle of records, rehearsals and shows. She has since described her relationship with fans using the image of a tree. "I was trying to tell them, I'm sorry, I don't have any apples to give you anymore," she said, "but we did not come for the apples; we came for the tree."

Dion is preparing to return to Paris this fall for her first extended run of pop concerts since the syndrome forced her off the road, following an emotional comeback appearance at the Paris Olympics. "It's been so long, I would like to offer them something to show how I've missed them," she said. Demand has reportedly been strong enough that the run has already been extended into 2027.